CNXC Earnings & Financial Statements
Concentrix Corporation
$26.66
-$0.30(-1.11%)
46
Overall
80
Value
10
Tech
50
Quality
Market Cap
$1.63B
Volume
1.04M
52W Range
$19.12 - $48.08
Target Price
$33.50
CNXC earnings and financial statements: Concentrix Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
CNXC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $9.83B | $9.62B | $7.11B | $6.32B | $195.70M |
| Cost of revenue | $6.39B | $6.17B | $4.54B | $4.07B | $140.00M |
| Operating income | -$918.18M | $596.39M | $661.33M | $640.19M | -$12.66M |
| EBITDA | -$207.89M | $1.35B | $1.00B | $986.39M | $150.17M |
| Net income | -$1.28B | $251.22M | $313.84M | $435.05M | -$14.72M |
| EPS (diluted) | $-20.36 | $3.71 | $5.70 | $8.28 | $-0.15 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $10.76B | $11.99B | $12.49B | $6.67B | $132.45M |
| Total liabilities | $8.02B | $7.95B | $8.35B | $3.97B | $65.41M |
| Shareholders’ equity | $2.74B | $4.04B | $4.14B | $2.70B | $67.03M |
| Cash and equivalents | $327.35M | $240.57M | $295.34M | $145.38M | $28.51M |
| Long-term debt | $4.57B | $4.73B | $4.94B | $2.22B | $19.87M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $806.97M | $667.49M | $678.01M | $600.72M | $3.60M |
| Capital expenditure | -$234.50M | -$238.76M | -$180.53M | -$140.02M | -$3.93M |
| Free cash flow | $572.47M | $428.73M | $497.48M | $460.70M | -$327.0K |
| Dividends paid | $89.62M | $83.81M | $63.49M | $53.43M | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CNXC | $26.66 | -1.1% | 1.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |